Expectations and Concerns Towards New Extended Half-Life (EHL) Products - Results of Surveys Among Haemophilia Patients from the Dach Region

被引：0
|
作者：
von Mackensen, Sylvia [1 ]
Kalnins, Werner [2 ]
Lino, Hostettler [3 ]
Joerg, Krucker [3 ]
Albisetti, Manuela [4 ,5 ]
Weiss, Josef [6 ]
Pabinger, Ingrid [7 ]
Oldenburg, Johannes [8 ]
机构：
[1] Univ Med Ctr Hamburg Eppendorf, Inst Med Psychol, Hamburg-Eppendorf, Germany
[2] German Haemophilia Soc DHG, Hamburg, Germany
[3] Swiss Hemophilia Assoc SHG, Altstatten, Switzerland
[4] Swiss Hemophilia Network SHN, Zurich, Switzerland
[5] Univ Childrens Hosp, Dept Hematol, Zurich, Switzerland
[6] Austrian Hemophilia Soc OHG, Vienna, Austria
[7] Med Univ Vienna, Dept Med I, Vienna, Austria
[8] Univ Clin Bonn, Inst Expt Haematol & Transfus Med, Bonn, Germany
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 46 条
  • [1] Patients Perspectives Concerning The New Extended Half-Life Products - Results of Patients Surveys From The Dach Region
    Von Mackensen, S.
    Kalnins, W.
    Hostettler, L.
    Krucker, J.
    Albisetti, M.
    Weiss, J.
    Pabinger-Fasching, I.
    Oldenburg, J.
    HAEMOPHILIA, 2017, 23 : 133 - 134
  • [2] Haemophilia patients' unmet needs and their expectations of the new extended half-life factor concentrates
    von Mackensen, S.
    Kalnins, W.
    Krucker, J.
    Weiss, J.
    Miesbach, W.
    Albisetti, M.
    Pabinger, I.
    Oldenburg, J.
    HAEMOPHILIA, 2017, 23 (04) : 566 - 574
  • [3] Extended half-life recombinant products in haemophilia clinical practice - Expectations, opportunities and challenges
    Chowdary, Pratima
    THROMBOSIS RESEARCH, 2020, 196 : 609 - 617
  • [4] Evaluation of treatment and outcome for patients with haemophilia A and haemophilia B on extended half-life (EHL) factor products: A 12-month data analysis
    George, Carly
    Parikh, Sumit
    Carter, Tina
    Mccosker, Joanna
    Carlino, Sara
    Tran, Huyen
    HAEMOPHILIA, 2023, 29 (05) : 1283 - 1290
  • [5] Single centre experience of switching from standard half-life to extended half-life products in patients with severe haemophilia A and B
    Phillott, Anica
    Stanley, Jenna
    Alamelu, Jayanthi
    HAEMOPHILIA, 2018, 24 : 32 - 33
  • [6] Improved arthropathy scores after use of Extended Half-Life (EHL) products in prophylactic treatment of adult patients with Haemophilia A & B
    Christidi, Styliani-Despoina
    Thevaeos, George
    Zannou, Anna
    Vlahopoulou, Dimitra
    Veziris, George
    Gavalaki, Maria
    Kourampa, Anna
    HAEMOPHILIA, 2023, 29 : 38 - 39
  • [7] COMPARATIVE ANALYSIS OF PHARMACOKINETIC (PK) STUDY DATA BETWEEN EXTENDED HALF-LIFE (EHL) AND STANDARD HALF-LIFE (SHL) FACTOR PRODUCTS: EXPERIENCE FROM GREEK ADULT HAEMOPHILIA CENTRE
    Christoforou, P.
    Kourampa, A.
    Varaklioti, A.
    Pirpiri, T.
    Balomenou, A.
    Katsarou, O.
    HAEMOPHILIA, 2023, 29 : 61 - 61
  • [8] Expectations and concerns towards the up-coming new long-acting products - results of a survey among haemophilia patients in Switzerland
    Von Mackensen, Sylvia
    Hostettler, Lino
    Krucker, Jorg
    Albisetti, Manuela
    HAEMOPHILIA, 2016, 22 : 57 - 57
  • [9] Expectations and Concerns Towards the Up-Coming New Long-Lasting Products - Results of a Survey Among Haemophilia Patients in Germany
    Von Mackensen, S.
    Struck, H.
    Kalnins, W.
    HAEMOPHILIA, 2016, 22 : 70 - 71
  • [10] Real-life experience in switching to new extended half-life products at European haemophilia centres
    Peyvandi, Flora
    Garagiola, Isabella
    Boscarino, Marco
    Ryan, Aislin
    Hermans, Cedric
    Makris, Michael
    HAEMOPHILIA, 2019, 25 (06) : 946 - 952
12345